BiOptix Diagnostics is a developer of a biomolecule detection system.
BiOptix Diagnostics is a developer of a biomolecule detection system. BiOptix developed an array-based biomolecule detection system that addresses many markets that currently cannot obtain the needed sensitivity and throughput in a single solution. It was founded in 2008 and is headquartered in Boulder, Colorado.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Oct 18, 2010 | Series B | $9M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
The Peierls Foundation | — | Series B |